Literature DB >> 1745492

Pregnancy-induced cytotoxicity of splenocytes against mammary tumor cells in rats.

P K Chakravarty1, S K Ghosh, D K Sinha.   

Abstract

Our earlier observations indicate the possibility of involvement of a 'host factor' in pregnancy-induced protection against mammary carcinogenesis. The present investigation is an attempt to determine if this "host factor" is of immunological nature. Rat mammary tumors induced by 7,12-dimethylbenz[a]anthracene were used as target, and splenocytes from parous rats of the same strain were used as effector cells. The parous rats were divided into two groups according to the time period after parturition. Group 1 contained rats which were 5-13 days after delivery, group 2 had rats 14 or more days after parturition. In vitro cytotoxicity was determined by incubating the tumor cells with spleen cells in the target:effector ratios of 1:3, 1:10 and 1:30. Both groups 1 and 2 showed significant lysis of mammary tumor cells. These results were confirmed by the trypan blue exclusion test. The results showed a significantly higher cytotoxic capability of the spleen cells from parous rats against mammary tumor cells as compared to spleen cells from age-matched nulliparous rats.

Entities:  

Mesh:

Year:  1991        PMID: 1745492     DOI: 10.1159/000226973

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  3 in total

1.  Inhibition of mammary tumorigenesis in virgin rats by adoptive transfer of splenocytes from parous donors.

Authors:  P K Chakravarty; D K Sinha
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis.

Authors:  L Rajkumar; R C Guzman; J Yang; G Thordarson; F Talamantes; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

3.  Parity improves anti-tumor immunity in breast cancer patients.

Authors:  Philipp Beckhove; Christoph Domschke; Anna-Lena Krause; Florian Schuetz; Marc Boudewijns; Maria Pritsch; Markus Wallwiener; Michael Golatta; Joachim Rom; Joerg Heil; Christof Sohn; Andreas Schneeweiss
Journal:  Oncotarget       Date:  2017-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.